Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The New England Journal of Medicine|February 12, 2015
Lenvatinib versus placebo in radioiodine-refractory thyroid cancerMartin Schlumberger, Makoto Tahara, Lori J Wirth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2013
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical OncologyJyoti D Patel, Lada Krilov, Sylvia Adams, et al.The New England Journal of Medicine|October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid CancerJulien Hadoux, Rossella Elisei, Marcia S Brose, et al.Thyroid : Official Journal of the American Thyroid Association|November 27, 2023
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW StudyVivek Subbiah, Mimi I Hu, Aaron S Mansfield, et al.Cancer Discovery|April 17, 2018
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven CancersVivek Subbiah, Justin F Gainor, Rami Rahal, et al.The Lancet. Diabetes & Endocrinology|June 12, 2021
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 studyVivek Subbiah, Mimi I Hu, Lori J Wirth, et al.Head & Neck|March 11, 2022
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatmentDavid C Shonka, Alan Ho, Ashish V Chintakuntlawar, et al.The New England Journal of Medicine|February 22, 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and ChildrenAlexander Drilon, Theodore W Laetsch, Shivaani Kummar, et al.Nature Genetics|October 6, 2009
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasAdam J Bass, Hideo Watanabe, Craig H Mermel, et al.Pageof 8